Search
linagliptin/metformin (Jentadueto XR)
FDA-approved May 2016 Indications: - diabetes mellitus type 2 Dosage: - QD dosing Tabs: - linagliptin 2.5 mg or 5.0 mg + metformin 1000 mgInteractions
drug adverse effects of hypoglycemic agentsGeneral
hypoglycemic combinationReferences
- RxNorm
- Tucker ME FDA OKs Linagliptin/Metformin Combo for Type 2 Diabetes Medscape: May 31, 2016 http://www.medscape.com/viewarticle/864030